Methanone, specifically the compound known as (4-bromo-5-fluoro-1H-pyrrol-2-yl)(3,5-dichloro-2-hydroxyphenyl)-, is an organic molecule characterized by its complex structure that includes a pyrrole ring and a phenolic moiety. The presence of halogen substituents, such as bromine, fluorine, and chlorine, contributes to its unique chemical reactivity and potential biological activity. The hydroxyl group on the phenyl ring enhances its polarity, which may influence solubility in various solvents. This compound may exhibit interesting pharmacological properties due to its structural features, making it a subject of interest in medicinal chemistry. Its molecular interactions can be influenced by the electron-withdrawing effects of the halogens, which can affect the compound's stability and reactivity. Additionally, the specific arrangement of substituents can lead to diverse applications in drug development and material science. Overall, this compound represents a fascinating example of how structural variations can lead to significant differences in chemical behavior and potential applications.

Methanone, (4-bromo-5-fluoro-1H-pyrrol-2-yl)(3,5-dichloro-2-hydroxyphenyl)-

2001602-07-7: Methanone, specifically the compound known as (4-bromo-5-fluoro-1H-pyrrol-2-yl)(3,5-dichloro-2-hydroxyphenyl)-, is an organic molecule characterized by its complex structure that includes a pyrrole ring and a phenolic moiety. The presence of halogen substituents, such as bromine, fluorine, and chlorine, contributes to its unique chemical reactivity and potential biological activity. The hydroxyl group on the phenyl ring enhances its polarity, which may influence solubility in various solvents. This compound may exhibit interesting pharmacological properties due to its structural features, making it a subject of interest in medicinal chemistry. Its molecular interactions can be influenced by the electron-withdrawing effects of the halogens, which can affect the compound's stability and reactivity. Additionally, the specific arrangement of substituents can lead to diverse applications in drug development and material science. Overall, this compound represents a fascinating example of how structural variations can lead to significant differences in chemical behavior and potential applications.

<p>Antibiofilm agent-9 (Compound 4), a derivative of pyrrolnitrin, exhibits antimicrobial activity. It inhibits Bacillus anthracis with a Minimum Inhibitory Concentration (MIC) of 0.031 μg/mL. The compound demonstrates significant antibiofilm activity, achieving an inhibition rate of 84% after 24 hours at a concentration of 8.0 μg/mL. Additionally, Antibiofilm agent-9 shows favorable pharmacokinetic properties in mouse models.</p>

CAS 2001602-07-7

Methanone, (4-bromo-5-fluoro-1H-pyrrol-2-yl)(3,5-dichloro-2-hydroxyphenyl)-

Antibiofilm agent-9

Ref: TM-T88641